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Available online 9 February 2015AbstractThe authors first reviewed the history of clinical application of artificial ligaments. Then, the status of clinical application of artificial lig-
aments was detailed. Some artificial ligaments possessed comparable efficacy to, and fewer postoperative complications than, allografts and
autografts in ligament reconstruction, especially for the anterior cruciate ligament. At the end, the authors focused on the development of two
types of artificial ligaments: polyethylene glycol terephthalate artificial ligaments and tissue-engineered ligaments. In conclusion, owing to the
advancements in surgical techniques, materials processing, and weaving methods, clinical application of some artificial ligaments so far has
demonstrated good outcomes and will become a trend in the future.
Copyright © 2015, Asia Pacific Knee, Arthroscopy and Sports Medicine Society. Published by Elsevier (Singapore) Pte Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Artificial ligaments were widely clinically adopted in the
1980s and 1990s in the reconstruction of anterior cruciate
ligament (ACL). Then, donor-site morbidity and disease
transmission were presented in the reconstruction of ACL
using allografts or autografts; by contrast, in a reconstruction
surgery using prostheses, all those adverse events could be
evaded.1 With such obvious advantages, they were seen as
promising devices. If clinically adopted, they would become
effective alternatives to the traditional methods of ACL
reconstruction. Furthermore, for most of those prostheses, the
primary outcomes were very encouraging, with lower
complication rates and good postoperative recovery.2e5 Based
upon these findings, various kinds of artificial ligaments were
invented and brought to clinics; each had its own specifica-
tions for the design pattern, weaving methods, and fabric
materials. However, after trials in clinics for 20 years, most of* Corresponding author. Department of Sports Medicine and Arthroscopy
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nthese prostheses were no longer used because of high
complication and failure rates.6e10 Nevertheless, some artifi-
cial ligaments survived and were still accessible in clinics,
such as the ligament augmentation reinforcement system
(LARS) and the LeedseKeio ligaments.11,12 Recently, novel
types of artificial ligaments (brand “Neoligaments”) were also
introduced in clinics, including artificial tendons and liga-
ments of knee, shoulder, and ankle joint.HistoryIn 1914, Dr Corner first made attempts to reconstruct a
ruptured ACL using a synthetic graft, which was just a piece
of silver filament. Afterwards in 1918, Smith tried to repair the
ACL using a silk ligament, but his attempt ended in failure 3
months later.13 Then, after being silenced for nearly 80 years,
synthetic grafts became popular in the 1980s and 1990s. The
advancement in the chemical industry and associated fields,
such as biomaterials, provided more suitable materials for
medical utilisation.
From then on, clinical application of artificial ligaments was
initiated. In October 1986, the Food and Drug Administratione Society. Published by Elsevier (Singapore) Pte Ltd. This is an open access
c-nd/4.0/).
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ACL reconstruction, followed by the 3M Kennedy ligament
augmentation device (LAD) in 1987 and the Stryker Dacron
ligament prosthesis in 1988.14 Other popular products were the
LeedseKeio ligament and the LARS. These two types were
adopted in Europe and Asia.
However, since the early 1990s, poor outcomes of long-
term follow-ups has halted the use of artificial ligaments. A
high incidence of complications such as reactive synovitis,
instability, loosening, and even rupture of the prostheses was
constantly reported.15e19
High postoperative complication rates inescapably doomed
nearly all these artificial ligaments, most of which eventually
faded out of market despite encouraging therapeutic effects in
early studies, such asGore-Tex and the LAD ligaments. In 2000,
Guidoin et al20 analysed polymer fibre-based replacements for
the ACL; they suggested that three elements played key roles in
the artificial ligament failure: (1) inadequate fibre abrasion
resistance against osseous surfaces; (2) flexural and rotational
fatigue of the fibres; and (3) loss of integrity of the textile
structure due to unpredictable tissue infiltration during healing.
While the development of surgical technique and refine-
ment of fabric materials used in the prosthesis production was
discontinued, artificial ligaments still existed in clinics, studies
of ligament reconstruction using prosthesis were also
constantly reported. LARS, due to its mechanical properties,
biocompatibility, and unique weaving method, showed good
clinical performance with low postoperative complication
rates and early rehabilitation. Evidence from clinical studies
showed that the LeedseKeio ligament can be used as a safe
and effective synthesis after certain refinements. As a relative
of the LeedseKeio ligament, Neoligaments is a new-born
force with many products designed for the tendon or liga-
ment deficiencies of knee, ankle, and shoulder.ClassificationPopular products of artificial ligaments include the Gore-
Tex cruciate ligament prosthesis, the 3M Kennedy LAD, the
Stryker Dacron ligament, the LeedseKeio ligament, and the
LARS. These products can be categorised according to their
design and materials.
According to their design philosophy, those artificial liga-
ments can be divided into four types namely: permanent type,
scaffold type, LAD type, and permanent scaffold type. These
prostheses are made of carbon fibre, polyethylene glycol
terephthalate (PET), and polytetrafluoroethylene.
Besides the aforementioned products, a novel type of arti-
ficial ligaments, called tissue-engineered ligaments, still re-
mains in the developmental stage.Early applicationDacron and carbon-fibre ligaments have been abandoned in
early clinical usage because of the occurrence of complica-
tions such as severe synovitis after the implantation of those
prostheses.10,21After being widely adopted in clinics, the use of Gore-Tex
faced a gloomy situation engendered by unacceptable clinical
results in following observations. Just as Paulos et al7 had
indicated in their report: “Early results of the Gore-Tex pros-
thesis used for ACL reconstruction showed low rates of failure.
Unfortunately, with extended follow-up, our rate of complica-
tions continues to increase. Mechanical failure, effusions, and
infections continue to occur”.
Indeed, there are voices that “ACL reconstruction using
Leeds-Keio ligament are as acceptable as those using PT, It
may provide an additional means of reconstruction where no
suitable alternative is present”.22 However, the fate of
LeedseKeio ligament is not much better than the Gore-Tex,
with adverse events constantly being reported in the follow-
ups.23e27
The autologous graft used in ACL reconstruction was
subjected to impaired strength after a few months owing to
necrosis, while the shrunken strength finally recuperated after
a period of about 1 year.28 To protect the vulnerable graft
during this period, an intra-articular LAD was developed by
Kennedy et al. Although this attempt seemed promising in
terms of its novel idea, LAD ligaments were ultimately
withdrawn from the market in 2000.9
Generally speaking, early applications of artificial liga-
ments were not successful. The bleak results of follow-ups
have revealed the underlying hazards: immune response, ef-
fusions, loosening, and rupture of the prostheses. Development
of artificial ligaments subsided at the end of the 20th century.
Current status in clinical application
During recent years, with the development of advanced
biomaterials and refined surgical techniques with better sur-
gical instruments, the interest of using synthetic grafts in lig-
ament reconstructions has been rekindled. When we begin to
talk about the current situation of artificial ligaments in clin-
ical applications, we must refer to LARS, which has long been
held in good grace by orthopaedists in China. Biomechanical
tests proved that the LARS ligament, weaved by PET,
possessed sufficient strength as a graft for ACL reconstruction.
After enduring a persistent traction of 1700 N and subsequent
relaxing in 1 day, the increase in length was < 1.5%.12 In
addition, the LeedseKeio ligament also served well in clinic
work.29e37 Although primarily designed for ACL reconstruc-
tion, the LeedseKeio ligament were generally adopted in
various conditions, such as rotator cuff tear,36 knee extensor
mechanism failure,7 Achilles tendon rupture,38 iliofemoral
ligament deficiency,34 and even ankle lateral ligament
rupture.31 In all these cases, the outcomes were satisfactory.LARS artificial ligament
Design of LARS
Taking warning from the failure of artificial ligaments in
early applications, the LARS was designed in a novel fashion.
The ligament was synthesised in two parts: the intraosseous
part and the intra-articular part. The bulk of the intraosseous
17T. Chen et al. / Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 2 (2015) 15e26part was composed of longitudinal fibres, which were bounded
together by transverse knitted structures, while the intra-
articular part was consisted of only longitudinal fibres,
which were pretwisted at 90. Logically, the intra-articular
parts of bilateral knees were separately manufactured.13
Fromearly failures of artificial ligaments, people have already
learnt the lesson that the lack of resistance to abrasion had caused
synovitis, predisposing to infection.39 The special design of the
LARS ligament with open fibres in its intra-articular part was
believed to be more resistant to torsional fatigue and wearing.
Furthermore, growing evidence in our studies suggested that
PET fibres of the intra-articular segment can induce ingrowth of
surrounding tissue owing to its open weaving method.12
In 2000, Lavoie et al40 first reported the clinical use of
LARS artificial ligaments in ACL reconstruction. The results
of their follow-ups indicated that the LARS artificial ligament
may be a safe device to reconstruct an ACL tear. Since then,
reports were constantly being published with different results,
and various opinions regarding clinical applications of this
synthesis were being discussed. In following paragraphs, the
use of the LARS artificial ligament in different conditions will
be discussed.
ACL rupture
In a study involving 42 cases from August 2004 to June
2005, Chen et al41 compared the early clinical outcomes of
ACL reconstruction using autogenous four-strand hamstring
tendons with LARS artificial ligaments. Their experience can
be recapitulated that patients using LARS artificial ligaments
enjoyed earlier recovery with better knee function than those
who adopted autogenous hamstring tendons in surgery. In Nau
et al's42 report, the investigators compared the clinical out-
comes and patient satisfaction between BPTB-bone patellar
tendon bone (BPTB) autograft group and the LARS artificial
ligament group in ACL reconstruction. Chen et al41 pointed
out that the early functional improvement had given LARS
artificial ligaments an edge over autografts. This particular
advantage made LARS a favourable choice for professional
athletes and people highly motivated by sports exercise. In
addition, Fremerey et al43 reported that most of the proprio-
ceptive recovery in ACL reconstruction using the BPTB
autograft occurred between 3 months and 6 months after the
operation, with deficiency still remaining in the mid-range
position. Considering the function of proprioception, they
suggested that an earlier return to full activity could be per-
ilous for patients using BPTB as a graft in ACL reconstruc-
tion. Thus, ACL reconstruction using LARS artificial
ligaments demonstrated better results in terms of early return
to sports and recreational activities.
In Gao et al's12 research, they noticed that for patients with
the ACL stump preserved in either acute or chronic injury, the
LARS ligament can be regarded as an ideal choice for ACL
reconstruction. This evidence suggested that the LARS artifi-
cial ligament was capable of inducing the tissue ingrowth,
based upon which the neoligament formation process can
initiate. The same outcome was also reported by Zaffagnini
et al44 in 2008, in which they scrutinised an intact LeedseKeioligament 20 years after implantation via histologic and ultra-
structural methods. Their description of the collagen fibril is
“very close” compared with the structure of the normal ACL.
Actually, these two types of artificial ligaments share a com-
mon ground: being capable of inducing the migration of fi-
broblasts and regeneration of native tissue, they are both made
of PET, a relatively premier material used in artificial ligament
fabrication so far.45
In 2011, Hamido et al46 evaluated the midterm results of
ACL reconstruction using a LARS artificial ligament for the
augmentation of the semitendinosus and the short-length and
small-sized gracilis. The suggestion derived from their 5-year
follow-up was that augmenting hamstring tendon graft with
LARS artificial ligaments was a useful, safe, and satisfactory
treatment option for ACL reconstruction with short and small-
sized harvested hamstring tendons, especially for patients
suffering from deficient knee who required an early return to
high-level sport activities. As we have already known, parti-
cles by tearing or abrasion, in all likelihood, played the evil
initiator in the very beginning process of synovitis.39 In this
logic, when the native augmentation of artificial ligament was
finally achieved, the lifespan and abrasion resistance of the
artificial substitution would be guaranteed to a certain extent.
To appraise the efficacy of LARS ligaments compared with
BPTB graft, Pan et al47 analysed the midterm outcomes of
ACL reconstruction using BPTB autografts or LARS liga-
ments between July 2004 and March 2006 in the follow-up of
62 cases. No significant difference was found between the
results of the two groups. Their retrospective study demon-
strated similar good clinical results after ACL reconstruction
using BPTB autografts and LARS ligaments at midterm
follow-up. Besides BPTB autografts, LARS ligaments can also
be listed as a satisfactory treatment option for ACL tear.
To ameliorate donor-site morbidities in ACL reconstruction
using BPTB autografts, hamstring tendon autografts have been
adopted as an alternative for their refined fixation techniques
and fewer donor-site morbidities.48 The hamstring autograft
was regarded as the most cost effective among three traditional
ACL graft types. As an autograft, this method still entails
functional deficiencies such as anterior knee pain, numbness,
and residual weakness postoperatively.49
In 2010, Liu et al50 carried out a retrospective study in 60
patients with a minimum of 4-year follow-up. The final results
showed that, after 4 years, ACL reconstruction using a LARS
ligament or 4SHG dramatically improved functional out-
comes; moreover, patients in LARS group finally recovered
with higher knee stability than those in the 4SHG group.
Posterior cruciate ligament rupture
A posterior cruciate ligament (PCL) injury is more often
caused by traffic accidents than by sports activities. Owing to
its specific structure, mechanical properties, and secluded
position, the surgical technique of PCL reconstruction is
demanding for both surgeons and grafts in knee surgery. The
aforementioned problems necessitated a novel method in PCL
reconstruction. LARS ligaments, owing to their special design
and fewer negative reports following ACL reconstruction
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in PCL reconstruction.
Huang et al51 explored the clinical outcomes of cruciate
ligament reconstruction under arthroscopy in 2010. Eighty-
one cases were involved; all patients received cruciate liga-
ment reconstruction using LARS ligaments under arthroscopy,
including 43 cases of ACL injury, 20 cases of PCL injury, and
18 cases of combined injury. Their research revealed that
ACL, PCL, or combined reconstruction using LARS ligaments
under arthroscopy could provide patients with satisfactory
short-term results. Shen et al52 analysed the preliminary
clinical effects of arthroscopic reconstruction of PCL using
LARS artificial ligaments. Forty-one patients who underwent
PCL reconstruction using LARS artificial ligaments were
enrolled in this retrospective study, and the average follow-up
period was 44 months. Evaluation criteria included the
Lysholm Knee Score and the International Knee Documenta-
tion Committee Score. Results of that research substantiated
their hypothesis that LARS artificial ligaments were effective
for PCL reconstruction, providing good knee stability. In 2013,
Smith et al53 presented the first systematic review of PCL
reconstruction using LARS artificial ligaments. Given
encouragingly low complication rates, LARS showed great
potential in PCL reconstruction. Although favourable out-
comes from short- and medium-term follow-ups supported the
use of LARS in PCL reconstruction, evidence from a limited
number of reports from clinics was not convincing; especially,
long-time efficacy of such synthesis was still not clear. Con-
cerning the long-term effect and optimal timing of surgery,
follow-up for longer periods is needed.
Notably, Ibrahim et al54 evaluated surgical treatment of
traumatic knee dislocation with a posterolateral corner injury.
PCLs were reconstructed with semitendinosus tendons and
reinforced with LARS ligaments. Albeit this study did not
focus primarily on PCL reconstruction, this trial indicated that
LARS ligaments held potential in the reconstruction of knee
ligaments for the restoration of joint stability in combined
injuries.
Dislocation of acromioclavicular joint
Surgical treatment of type IVeV and VI dislocations of the
acromioclavicular joint (Rockwood's type) is demanding.
Complications such as postoperative instability, delayed
arthrosis, and deficient osteolysis of clavicle and the need of
early mobilisation of the affected upper limb are hard to bal-
ance in clinic work.55 In 2010, Fraschini et al56 compared the
outcomes of two surgical procedures of coracoclavicular joint
reconstruction. Acromioclavicular joint (AC) reconstruction
with a LARS artificial ligament showed better results than that
with a Dacron vascular prosthesis. They recommended
anatomic AC reconstruction with LARS for the surgical
treatment of chronic complete AC dislocations, due to its
satisfactory functional outcome and low complication rate. In
2013, Giannotti et al55 reported a midterm follow-up of 17
patients who were suffering type IVeV and VI dislocations of
the acromioclavicular joint; based on thorough clinical and
radiographic evaluation, the patients were evaluated in anobjective manner. They thought that reconstruction of the
conoid and trapezoid ligaments with LARS artificial ligaments
was a safe and effective alternative to other procedures. The
same year, Lu et al57 evaluated the outcomes of cor-
acoclavicular reconstruction with LARS artificial ligaments
for the treatment of acute complete AC joint dislocation; 24
patients were involved. Their voice, to a certain extent, echoed
that of Giannotti et al.55
Complications
LARS artificial ligaments have already been applied in
ACL reconstruction for many years, and reports showing
positive results in short and mid-terms were abundant. How-
ever, concerns exist regarding the potential risks of compli-
cations. Lavoie et al40 compared satisfaction levels of 47
patients and assessed early complications after ACL recon-
struction using a LARS artificial ligament by reviewing them
8e45 months after surgery. No clinical evidence of synovitis
or other minor complications was found; they suggested that a
LARS artificial ligament might be a safe device to reconstruct
the ACL. However, in many cases, a lack of symptoms can
mask the synovitis afflicting patients; for researchers, over-
looking a mild synovitis can affect judgement in clinic work.
In short, synovitis in the moderate stage cannot be detected
through physical examination in daily work. This indicates
that for the artificial ligaments used in clinics, asymptomatic
results do not mean that grafts helped in the healing process.12
Li et al58 recently reported a rare case of serious synovitis in
a 26-year-old man who had undergone ACL reconstruction
using LARS artificial ligaments 3 years previously. In arthro-
scopic revision, they observed a large amount of synovial hy-
perplasia in the knee joint, containing a large amount of
hemosiderin deposition. Apart from that, the position of the
femoral tunnel was too anterior, with the graft rupturing near
the tibial tunnel. Thick fibrous scar tissues around the graft
were found by histological observation, and it was suggested
that those poorly organised fibrous scar tissues could infiltrate
into the graft fibres, causing a loss of structural integrity of the
prosthesis and eventual graft failure. In conclusion, their find-
ings indicated that further in-depth research on artificial liga-
ments was necessary for their further development. According
to Amis and Kempson's59 study, ACL implant failure was often
caused by bone impingement in knee extension after malposi-
tioning of the tibial tunnel. In this case, the femoral tunnel was
placed too anteriorly, while the ligament was ruptured near the
tibial tunnel. Malposition of the implant should not be
neglected, considering that it may cause severe synovitis.
In 2012, Glezos et al60 reported a case of disabling syno-
vitis 1 year after LARS artificial ligament implantation. In
their report, the complication was so severe that we should
give a second thought to the implantation of LARS ligaments
in young and active patients. Moreover, focal degenerate
change in the subsynovial layer was noticed through histo-
logical observation. This pathomorphological change was
presumed to be the pivotal stage between synovitis and
ensuing degenerative arthritis. As we know, synovitis is caused
by a foreign body during abrasion and tearing of the graft. If
Table 1
Reports on clinical use of LeedseKeio ligament part 1.
Study type Reconstructed
structure
Publication
year
Follow-up
time (mo)
Patients Investigator Results
Retrospective ACL 1991 24e48 20 Macnicol et al23 Poor self-tissue regeneration under arthroscopy; synovitic
reaction
Retrospective ACL 1994 12e60 68 Schroven et al24 Laxity; lack of collagenisation and ingrowth of tissue
Retrospective ACL 1995 24 24 Rading and Peterson25 Three ruptures; six significant instability
Retrospective ACL 1995 60e84 50 Denti et al26 Five subsequent failures
Retrospective ACL 2004 120e192 18 Murray and Macnicol27 Rupture; poor function
ACL¼ anterior cruciate ligament.
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uation of early generations of artificial ligaments struck again.
However, it is worth mentioning that Glezos's paper was very
complex, considering the fact that the injuries included com-
plete rupture of the ACL and medial collateral ligament, a
partial PCL injury, and a minor depression fracture of the
lateral tibial plateau. What is more, as a military officer
serving overseas missions, the patient did not evacuate to
Australia until 10 days after being hit by an improvised
explosive device. People familiar with war wounds are aware
of the simple fact that war injuries, especially those caused by
lethal shrapnel, are not as curable as common accident
injuries.LeedseKeio ligamentsAs the predecessor of Poly-Tapes (Neoligaments; Xiros Plc,
Leeds, UK), LeedseKeio ligaments have been clinically
adopted since 1982.61 It is a permanent prosthesis invented by
the University of Leeds and Keio Universitydhence the name.
Made of polyester fibres, this synthesis was specifically
developed for ACL reconstruction, with its mechanical prop-
erties mimicking those of the natural ACL. The clinical effi-
cacy of this product was a controversial topic considering the
various results from clinic reports. Adverse events such as
rupture of the synthesis, synovitis caused by wearing particles,Table 2
Reports on clinical use of LeedseKeio ligament part 2.
Study type Reconstructed structure Publication
year
Investigation
time (mo)
Patients
Retrospective ACL 1992 60 25
Retrospective ACL 1999 d 82 knees
Retrospective Lateral ligament of the
ankle joint
2000 68 451 feet of 436
patients
Retrospective MPFL 2000 68 27 knees
Retrospective Extensor mechanisms 2003 36 12 knees
Case report Iliofemoral ligament 2003 d One knee
Retrospective MPFL 2005 11e109 15 knees
Prospective
controlled
Rotator cuff 2006 24 20 LeedseKeio
19 autograft
Retrospective ACL 2006 12 17
ACL¼ anterior cruciate ligament; LK¼ LeedseKeio; MPFL¼medial patellofemand poor functional recovery were frequently reported be-
tween 1991 and 2004. More details of these reports are listed
in Table 1.
Early in 1994, Schroven et al24 reported that they found a
marked increase in laxity over the period of investigation.
Biopsies were taken during arthroscopic examination of sus-
pected ruptures. Tests proved that the collagenisation and
tissue ingrowth were insufficient of these specimens.
In 2004, Murray and Macnicol27 reported a 10e16-year
follow-up of ACL reconstruction using the LeedseKeio liga-
ments; the bleak results were very worrying as nearly 28%
patients experienced synthesis rupture, 56% had increased
laxity, and all postoperative knees had radiographic signs of
degeneration compared with a lower rate of only 39% in the
contralateral knees. Furthermore, they pointed out that in
addition to the poor overall outcome of this long-term follow-
up, the incidence of osteoarthritis in these relatively young
patients was a more concerning issue in LeedseKeio ligament
application.
However, the reports of clinical use of the LeedseKeio
ligaments soon improved after 2000, with reports constantly
demonstrating positive outcomes. More details about these
reports are listed in Table 2.
Keeping in mind the aforementioned defects of insufficient
tissue ingrowth and collagenisation by Schroven et al,24
Sugihara et al37 in their research adopted a novel type ofInvestigator Opinion
Mcloughlin and
Smith29
A simple alternative in the chronic anterior
cruciate-deficient knee
Matsumoto et al30 Stability achieved, joint laxity diminished immediately
Usami et al31 Excellent results in long-term follow-up
Nomura et al32 A safe and effective choice in MPFL reconstruction
operation
Toms et al33 Favourable results compared with other techniques
Fujishiro et al34 Useful in difficult cases of recurrent THA dislocation
Nomura et al35 Mature connective tissue observed in specimens 5 y
postsurgery
; Tanaka et al36 An acceptable alternative for repairing rotator cuff
undergoing total shoulder arthroplasty
Sugihara et al37 Superior tissue induction and maturation of LK II
compared with LK I
oral ligament; THA¼ total hip arthroplasty.
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struction. After the radio frequency-generated glow discharge
procedure, the ligament demonstrated superior capability in
tissue induction and maturation compared with the primary
type of LeedseKeio ligament. With a second look at Murray
and Macnicol's27 report, with merely 18 patients being included
in their research, the evidence based on only a limited sample
size does not seem very convincing.
Fujishiro et al34 documented the use of LeedseKeio liga-
ment in the reconstruction of the iliofemoral ligament of an
86-year-old woman. The patient sustained poor anterior
acetabular covering in the standing position; while the hip
stability was confirmed in 1-year follow-up, no further dislo-
cation of hip ever happened. The LeedseKeio ligament, which
was originally developed for ACL reconstruction, performed
well in this case. Fujishiro et al's34 trial inspired us that when
facing difficult problems of soft-tissue deficiency, the ampli-
fied application scope of artificial ligaments may serve well
with good clinical result.
LeedseKeio ligaments can also be used to tackle the
challenging problem of extensor mechanism deficiency,
especially in the patients with early arthroplasty.33,62 In 2005,
Sherief et al63 carried out a study in order to appraise the
outcome of the reconstruction of a deficient extensor mecha-
nism using a Leeds-Keio connective tissue prosthesis in a total
knee replacement. The outcome of their study was impressive,
with all the patients having good functional recovery without
an extension lag owing to the restoration of knee extensor
mechanism. In 2008, Rust et al64 described the use of the
LeedseKeio ligament in the reconstruction of a neglected
quadriceps tendon rupture after a knee arthroplasty revision, as
they indicated in the paper, “The LeedseKeio ligaments may
also be an effective alternative to address deficiencies of the
quadriceps tendon, with good function for 2 years”.
Generally speaking, outcomes from other research works in
recent years have given out encouraging information. These
studies have shown favourable outcomes, and the supportive
attitude in these reports was unanimous.NeoligamentsNeoligaments, prostheses made of polyester (Dacron), have
been reported in clinical application. In 2010, Nada et al65
described a surgical technique in the augmentation of
chronic massive tears of rotator cuff using a novel polyester
ligament. All 21 patients were free from pain with improve-
ment in function and range of movement. The mean pre- and
postoperative constant scores were 46.7 and 85.4, respectively.
The mean patient satisfaction score was 90%. There were two
failures, one due to a ruptured ligament after 1 year and the
other due to deep-seated infection. A magnetic resonance scan
at the final follow-up confirmed intact and thickened bands in
15 of 17 patients. Similar to LeedseKeio ligaments, Neo-
ligaments also included products applied in tissue repair fields
such as rotator cuff patch, Ploy Type, and so on.66 Further
studies of short- and long-term follow-ups are still needed to
confirm their efficacy in clinical application.Advancements in basic research
High tensile strength, abrasion resistance, and no immune
reaction should be listed as the basic properties of an ideal
material used in artificial ligament manufacture. In addition,
the prosthesis should be capable of mimicking the native
ACL by allowing the ingrowth of surrounding tissue in
physiological manner, by which normal function of the ACL
would be restored. However, artificial ligaments with these
qualities have not yet been developed; even in ACL recon-
struction using the BPTB and semitendinosus and gracilis
(STG) grafts, the ligament healing process is still not fully
clear. The microenvironment, growth factors, appropriate
stress, etc. have been proved as key elements in the neo-
ligament progress,67,68 which is initiated by revascularisation
in the grafts. An understanding of how we can modulate all
these elements in a correct way still needs further explora-
tion. Our experience in this field is still limited, albeit some
encouraging findings were constantly reported.Refining of PET artificial ligamentAs a permanent artificial graft in the bone tunnel, tissue
integration of an artificial ligament is a mainstay in the
fixation of a graft, which concerns the prognosis in the
reconstruction of cruciate ligament. Previous reports indi-
cated that poor osseointegration of an artificial ligament with
the surrounding bone is due to its hydrophobicity and
chemical inertia.69e72 Logically, refinement of PET mate-
rials is a promising direction in the development of artificial
ligaments.
Li et al73,74 reported that composite coating of 58S bioglass
and hydroxyapatite could enhance osseointegration of a
polyethylene terephthalate artificial ligament in the bone
tunnel. In 2013, application of the layer-by-layer hyaluronic
acidechitosan coating on a PET scaffold was confirmed to be
an effective procedure in inducing new collagen into the graft
fibres.75
In 2013, Lessim et al76 studied the effect of surface treat-
ment of LARS ligaments using poly(sodium styrene sulpho-
nate). The results demonstrated improvement of knee
functionalities and a better adhesion of human cell lines. It
was proved that the poly(sodium styrene sulphonate) grafting
was a useful method in inducing fibroblast organisation, and
collagen and decorin deposits. Yang et al77 described a new
strategy to enhance artificial ligament graft osseointegration in
the bone tunnel using hydroxypropyl cellulose; the data of
their study showed that the surface treatment of PET artificial
ligament using hydroxypropyl cellulose might enhance graft
osseointegration in the bone tunnel.
PET artificial ligaments now act as the main force in the
clinical application of artificial ligaments, with the LARS and
LeedseKeio ligaments being widely used in Europe and Asia.
Based on this, the development of such graft is full of chal-
lenges and opportunities considering the huge potential mar-
kets, while the step from the laboratory to the operation theatre
is a challenge for all investigators.
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corporates several fields including biological, medicine,
application engineering, and materials science. The ultimate
goal of this research area is to regenerate tissue, replace the
impaired structure, and finally restore the normal function.67
Specifically, the field of tissue engineering has four basic
constituent parts: selection of seed cell, biomaterial scaffold
fabrication, growth factor adaptation, and mechanism condi-
tioning. For the first time gaining ground in the late 1980s by
Langer and Vacanti, incorporation of these four components in
the tissue-engineering domain was deemed as an underlying
paradigm in following researches.78 In the tissue-engineering
artificial ligament field, the research area mainly focuses on
ACL reconstruction, as it has been reported that over 200,000
patients are diagnosed with ACL rupture every year, making it
one of most common ligament injuries of the knee.79 How-
ever, the limitations of tissue-engineered artificial ligament are
their poor healing capacity and the peculiar mechanical
properties of the ACL.
Due to the intra-articular location, the ACL does not heal
after injury; in addition, the native formation process of the
ACL has not yet been well determined.68 Thus, efforts in ACL
tissue engineering are mainly based upon the comprehension
of the medial collateral ligament healing.80 Compared with the
ACL, the medial collateral ligament is an extra-articular lig-
ament, which is capable of healing without any surgical
treatment because of the formation of hematoma after the
ligament injured.81 According to the study of Pascher et al,82
the hematoma can be regarded as a provisional chemotactic
scaffold that lays the foundation for ligament repair. By
contrast, in case of ACL injury, the situation is different, and
the intra-articular environment presents a huge challenge.
Notably, Murray and Spector83 already found that ACL fi-
broblasts were capable of proliferating and migrating onto a
scaffold in an in vitro experiment, which again indicated that
the intra-articular environment played an important role in
blocking the ACL healing process; by contrast, the ACL was
proved not inherently unable to heal. The following sub-
sections briefly discuss about several advancements of the
aforementioned components in the tissue-engineering artificial
ligament field.
Seed cells
The choice of the seed cell is vital in the tissue engineering
approach in ACL reconstruction. Qualified seed cells must
meet three conditions: (1) easily available; (2) potent to pro-
liferate; and (3) efficient in elaborating mature extracellular
matrix (ECM).68
Commonly, ligament fibroblasts are the first option for
ACL regeneration, but their comparatively modest prolifera-
tive ability hindered further utilisation.84 While the develop-
ment of stem cell technology offered investigators more
choices in the selection of seed cell, pluripotent and multi-
potent stem cells were generally adopted for ligament tissue
engineering. With more and more reports published bydifferent investigators, the use of stem cells became a trend in
this field. Stem cells used in tissue engineering mainly include
bone marrow-derived mesenchymal stem cells,85e87 adipose-
derived stem cells,88,89 perivascular stem cells,90 and human
foreskin fibroblasts (HFFs).91
The most popular adult stem cells used in tissue-engineered
ligaments are bone marrow-derived mesenchymal stem cells,
which have demonstrated many advantages such as high po-
tential in differentiation and easy availability in harvest via
aspirating bone marrow without unavoidable surgery.84,92,93
However, a tendency of cellular senesce, loss of multi-
differentiation potential, as well as enormous heterogeneity
with low effective stem cell output fettered the utilisation of
autologous bone marrow stem cells.93 Perhaps, novel cell
leaching techniques and cellular transfection of telomerase
gene will solve the identification problem in the future.
Similar to bone marrow-derived mesenchymal stem cells,
adipose-derived stem cells were also proved to have prolifer-
ation capacity and differentiation potentials; furthermore, stem
cells can be harvested during liposuction, making them readily
available.89 However, defects such as heterogeneity in cellular
harvesting and inconsistent expression of ligament markers
during in vitro experiment indicate that it cannot be chosen as
an ideal seed cell in tissue-engineered ligaments.88
HFFs, as FDA-approved seed cells used in Dermagraft skin
substitute, are characterised by their immunoregulation prop-
erties, easy availability and homogeneity. It is worth pointing
out that HFFs are not stem cells despite their proliferation
ability and they represent the first human-derived tissue en-
gineering product approved by the FDA.94,95
Having a latent role in ligament tissue engineering, the
perivascular stem cells are actually a subset of the mesen-
chymal stem cells mainly found in the vasculature. In 2009,
Tempfer et al96 found that these cells express cellular markers
of both stem cells and tendon cells. The morphology of these
multipotent stem cells resembled that of traditional mesen-
chymal stem cells, according to Crisan et al's97 report.
Although the aforementioned seed cells adopted in the
tissue-engineered ligament were successively reported by in-
vestigators, the reality is that the exact details of cellular
behaviour and their interaction with surroundings in vivo are
still unclear.
Growth factors
Growth factors were widely accepted as intrinsic regulators
in almost all the cellular physiological activities including
proliferation, differentiation, ECM elaboration, and even me-
chanical behaviour. Logically, approaches using growth factors
for tissue-engineered ligaments should be fully investigated.
The methods using factors, were abundantly reported.
Numerous researches demonstrated that growth factors adopted
in tissue engineering can promote cellular proliferation, stem
cell differentiation, and matrix formation. However, the specific
signal pathway of certain growth factors and their mutual
interaction during ligament healing process are still not explicit.
Until now, the growth factors applied in tissue-engineered
ACL include platelet-derived growth factor, transforming
Table 3
Natural materials used in tissue-engineered ligament scaffolds.
Natural materials Representative
investigators
Publication
year
Advantages Defects
Collagen Dunn et al110 1995 Biocompatible; about 90% of native ACL Insufficient mechanical strength;
immunogenicity
Silk Chen et al111 2003 Good tensile strength Insufficient cell affinity; immunogenicity
Hyaluronic acid Cristino et al112 2005 Biocompatible; natural ingredient of ECM; variable usable
forms
Insufficient mechanical strength
Chitosan Shao et al113 2010 Biocompatible; chemically modifiable; variable usable forms Insufficient cellular affinity; insufficient
mechanical strength
Alginate Yamane et al114 2005 Biocompatible, enveloping effect, variable usable forms Lacking mechanical strength
ACL¼ anterior cruciate ligament.
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factor, growth and differentiation factor, and insulin-like
growth factor. As mentioned earlier, all these factors have
exhibited the capacity for regulating cellular proliferation,
stem cell differentiation, and ECM elaboration, whereas in
some studies, the effects of the growth factors were found to
be inconsistent.98 According to reports by Vavken et al,99 age-
dependent expression of growth factors can explain the
phenomenon.
The use of platelet-rich plasma for histological repair on a
collagen scaffold was reported by Murray et al in 2007.100 The
result of their study proved that a collageneplatelet-rich
plasma scaffold can ameliorate histologic disparity of intra-
articular ligamentous wounds compared with the extra-
articular ligamentous wounds. In 2011, Darabos et al101
adopted autologous conditioned serum that contains growth
factors and other cytokines as a novel method in postoperative
treatment of ACL reconstruction. The result of their rando-
mised control trials suggested that the intra-articular injection
of the autologous conditioned serum can prevent bone tunnel
widening after the ACL reconstruction surgery. However, the
variability of the components of either the autologous condi-
tioned serum or the platelet rich plasma (PRP) and the relative
immaturity of the preparation technique hindered the clinical
application of such novel treatments.102,103
Recently, the investigation on growth factor adaptation was
generally centred on the controlled delivery of growth factors
through some degradable biomaterials, while the final results
still need to be tested by time.
According to our knowledge from animal experiments, the
long-time effective and stable release of drugs (growth factors)
and maintaining them at a native physiologic level in the intra-
articular environment are pivotal in research. However, theTable 4
Degradable biomaterials used in tissue-engineered ligament scaffolds.
Degradable
polymers
Representative
investigators
Publication
year
Advantages
PLGA James et al115 2011 Controllable degradation rate; techn
PGA Lin et al116 1999 Technologically mature
PLLA Lu et al117 2005 Slow degradation rate; better cell af
mature
PGA¼ poly(glycolic acid); PLGA¼ poly(lactic-co-glycolic acid); PLLA¼ poly(l-detailed healing process of the natural ACL is still opaque
within our current horizon, although the mechanism of such a
complex tissue-engineered work should be crystal clear.
Biomaterial scaffolds
Biocompatibility and mechanical strength are two key
properties when we assess a scaffold used in a tissue-
engineered ligament.104 Besides, the proper rate of biodegra-
dation is also a decisive factor for the regeneration of soft
tissue.105 In the research of tissue-engineered ligaments, many
biomaterials have been adopted, which demonstrated encour-
aging advantages at first glance. However, some studies un-
covered their defects, including those of natural materials
(Table 3), biodegradable polymers (Table 4), and novel mixed
composites, which took the form of chimeras. Undeniably,
great advances were witnessed in the research of biomaterials
used in the tissue-engineered ligament program during recent
years.106,107 It is a trend that more and more “chimeras” will
be created in further investigations, in hopes of combining
merits of different materials and ameliorating or even obvi-
ating their drawbacks with a novel composite.108 However, to
our knowledge, the native structure of the ACL is still a
controversial topic, which makes the geometry of native lig-
ament another difficult issue in designing a scaffold.109 Thus,
designing a scaffold that meets the three aforementioned as-
pects will still require much efforts; specifically, mechanical
properties in vivo, degradation characteristics of novel scaf-
folds, and advanced methods of scaffold manufacturing tech-
niques will be under investigation for some time.
Mechanical condition
Early in 1982, in their research on mechanical properties of
tendons and ligaments, Woo et al118 studied the effects ofDefects
ologically mature Biologically inert; acidic degradation by-products
Ready degradation; insufficient mechanical strength;
hydrophobicity; adverse degradation product
finity; technologically Hydrophobicity; adverse degradation product
lactic acid).
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study, they analysed the possible mechanisms of the difference
in tissue responses under different conditions. Later on, in a
trial on rabbit model in 1987, they found that the mechanical
properties and morphological characters of the medial collat-
eral ligament were influenced after immobilisation and
remobilisation.119 Then in 1999, Woo et al120 detailed the
biomechanics of knee ligaments. It's presumable that as one of
the main stabilisers of the knee, the ACL is susceptible in such
a complex mechanical condition. As a result of the mechanical
influence, cellular endogenous changes, tissue structure, and
biomechanical properties of the ligament vary to adapt to the
stimuli. Altman et al121 pointed out that even in the absence of
growth factors in the experiment, the mechanical stress still
promotes cellular differentiation. In 2006, Henshaw et al's122
research on canine ACL fibroblasts consolidated that the
integrin acted as a mediator in the cellular focal adhesions
caused by mechanical stimuli; a former report described that
deformed cytoskeleton can also trigger the cellular response to
mechanical stress.123 Apart from the growth factor, which
works in an extremely complicated network, the influence of
mechanical condition of the ACL physiology makes the tissue-
engineered ligament a more challenging issue than we once
expected. To determine an appropriate mechanical stimulation
regimen for tissue-engineered ligaments, further researches
should be centred on the elucidation of the basic mechanism
underlying the formation and maintenance of the natural lig-
ament, especially the ACL. Investigators should recognise that
humans are still fledgling explorers in understanding the me-
chanical condition of natural ligament, as well as in gaining
the applicable knowledge in tissue-engineered ligaments.
It is undeniable that tissue-engineered ligament researches
have progressed in the past decades. In some aspects, our
increasing understanding can be literally claimed as break-
throughs, by which we laid the cornerstone of this field. How-
ever, the development of a qualified tissue-engineered ligament
is still full of challenges owing to the insufficient understanding
of natural ligament healing and development in vivo, specif-
ically for the ACLdthe most focused tissue-engineered liga-
ment. Based on the promising results of relative studies, such as
the encouraging clinical trial of L-C ligament, we believe that a
continuing progress in the research of tissue-engineered liga-
ments will lead to a viable product in the future.124
Conclusion
Compared with autografts or allografts used in ligament
reconstruction, artificial ligaments possess unique advantages
such as no donor-site morbidity, early recovery, and no risk of
disease transmission. Inspired by this novel idea, many syn-
thetic ligaments were clinically adopted in the past 20 years of
the 20th century; however, the postoperative complications
such as infection and rupture of graft intercepted their clinical
utilisation. Consequently, only a few of them survived, with
the FDA generally removing synthetic ligaments from the
United States market. However, one reality we must concede
that synthetic ligaments such as the LARS and LeedseKeioligaments are still clinically adopted in Europe and Asia;
furthermore, according to our studies and those carried by
researchers with short- and middle-term follow-ups, synthetic
ligaments performed well, at a parallel level with, if not better
than, the traditional reconstruction methods using allografts or
autografts. As for the issue of tissue-engineered ligaments, we
believe that they are promising devices in future clinical work;
however, limited by our current knowledge in such fields, for
transferring a qualified product from the laboratory to the
operation theatre, there is still plenty of work to do.
Considering the widened scope of artificial ligaments
adaptation in clinics recently, the authors believe that, like any
novel techniques now profoundly influencing our lives within
a short period of time after being introduced, clinical uti-
lisation of artificial ligaments will become an irreversible
trend in the future despite its failures at early attempts.
A better tomorrow is only a matter of time.
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